Lung Cancer Detection Rates in Early Screening Initiatives within the Mississippi Delta
-
By
-
Wei Liao
-
Simon Tye
-
Jordan Goss
-
Carrie Fehnel
-
Meredith Ray
-
Raymond U. Osarogiagbon
-
April 13, 2026
-
Clinical Scorecard: Lung Cancer Detection Rates in Early Screening Initiatives within the Mississippi Delta
At a Glance
| Category | Detail |
| Condition | Lung Cancer |
| Key Mechanisms | Low-dose computed tomography (LDCT) screening reduces lung cancer mortality and improves early-stage diagnosis. |
| Target Population | Diverse populations in the Mississippi Delta with high lung cancer incidence and mortality rates. |
| Care Setting | Community-based health care system serving socioeconomically diverse patients. |
Key Highlights
- NLST showed a 20% reduction in lung cancer mortality with LDCT screening.
- Increased use of curative-intent treatment linked to early-stage diagnosis.
- Diverse patient enrollment in incidental pulmonary nodule (IPN) programs.
- Study approved by Institutional Review Board with low risk to participants.
- Data collected from 2015 to 2024, focusing on demographic and clinical characteristics.
Guideline-Based Recommendations
Diagnosis
- Use of Lung-RADS scoring system for categorizing lung nodules.
Management
- Follow Fleischner Society guidelines for triaging patients with IPNs.
Monitoring & Follow-up
- Regular follow-up LDCT screenings based on Lung-RADS scores.
Risks
- Consideration of race and socioeconomic factors in lung cancer risk assessment.
Patient & Prescribing Data
Patients enrolled in LCS and IPN programs at BMHCC.
Increased early-stage diagnosis leads to improved survival outcomes.
Clinical Best Practices
- Implement guideline-concordant treatment for incidentally detected pulmonary nodules.
- Utilize community health initiatives to reach diverse populations.
References